With a strong track record in the life sciences and healthcare sectors, the fund manager brings extensive experience in identifying and nurturing promising startups. Active across Europe and North America, they have successfully executed over 30 deals, demonstrating a keen ability to strategically invest at early and growth stages. Notable exits include several high-profile acquisitions that showcase their operator-first approach. Their investment style combines thematic insights with data-driven analysis, ensuring a robust portfolio that aligns with emerging market trends.